These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8719370)

  • 21. Surveillance or lymph node dissection in clinical stage I non-seminomatous germinal testis cancer?
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L
    Br J Urol; 1985 Dec; 57(6):759-62. PubMed ID: 3002535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reduced retroperitoneal lymphadenectomy for clinical stage I non seminomatous germ cell testicular cancer].
    Valdevenito Sepúlveda JP; Merhe Nieva E; Valdevenito Sepúlveda R; Cuevas Toro M; Gómez Gallo A; Bermúdez Luna H; Contreras Meléndez L; Gallegos Méndez I; Gallardo Escobar J; Palma Ceppi C
    Arch Esp Urol; 2007 Apr; 60(3):245-54. PubMed ID: 17601299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
    Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
    Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I.
    Fosså SD; Klepp O; Ous S; Lien HH; Stenwig AE; Abyholm T; Kaalhus O
    Eur Urol; 1984; 10(1):17-23. PubMed ID: 6698081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
    Hiester A; Che Y; Lusch A; Kuß O; Niegisch G; Lorch A; Arsov C; Albers P
    Eur Urol; 2023 Jul; 84(1):25-31. PubMed ID: 36372627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
    Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
    Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph node dissection in testicular cancer.
    Jacobsen NE; Foster RS; Donohue JP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
    Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
    Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?
    Basiri A; Ghaed MA; Simforoosh N; Tabibi A; Danesh A; Nouralizadeh A; Parizi MK
    Urol J; 2013; 10(2):873-7. PubMed ID: 23801470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.
    Albqami N; Janetschek G
    J Endourol; 2005; 19(6):683-92; discussion 692. PubMed ID: 16053357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
    J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative, radio-guided sentinel lymph node mapping in laparoscopic lymph node dissection for Stage I testicular carcinoma.
    Satoh M; Ito A; Kaiho Y; Nakagawa H; Saito S; Endo M; Ohyama C; Arai Y
    Cancer; 2005 May; 103(10):2067-72. PubMed ID: 15803493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?
    Sosnowski M; Jeromin L; Płuzańska A
    Int Urol Nephrol; 1994; 26(4):471-7. PubMed ID: 7528180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.